| 000 | 01442 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517145434.0 | ||
| 264 | 0 | _c20170905 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1879-3649 | ||
| 024 | 7 |
_a10.1016/j.vph.2017.03.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBehl, Tapan | |
| 245 | 0 | 0 |
_aRole of altered coagulation-fibrinolytic system in the pathophysiology of diabetic retinopathy. _h[electronic resource] |
| 260 |
_bVascular pharmacology _c05 2017 |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aAntithrombin III _xmetabolism |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xblood |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xmetabolism |
| 650 | 0 | 4 | _aRetinal Neovascularization |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_avon Willebrand Factor _xmetabolism |
| 700 | 1 | _aVelpandian, Thirumurthy | |
| 700 | 1 | _aKotwani, Anita | |
| 773 | 0 |
_tVascular pharmacology _gvol. 92 _gp. 1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vph.2017.03.005 _zAvailable from publisher's website |
| 999 |
_c27039405 _d27039405 |
||